Blood Banking vs Plasmapheresis: Understanding the Distinction
5 min read
AUTHOR

MEDICALLY REVIEWED BY


"Blood banking" and "plasmapheresis" are two terms readers often encounter together and assume are interchangeable. In reality, blood banking vs plasmapheresis is a comparison between two different processes: one is a donation and storage system, and the other, when used therapeutically, is a medical treatment performed on a patient. Blood banking collects, tests, stores, and distributes blood and plasma donated for someone else's benefit, while plasmapheresis performed as Therapeutic Plasma Exchange (TPE) removes substances from a patient's own plasma to help manage a diagnosed condition. This article, from Humanaut Health, explains what each process is, how they compare, why they get confused, and how safety and oversight differ.
What Is Blood Banking?
Blood banking is the system that collects, tests, processes, stores, and distributes blood and blood components, including whole blood and apheresis-collected plasma, platelets, or red cells, from healthy donors. The donated material is intended for transfusion to another person or for further manufacture into products such as immunoglobulin. Because the donor is healthy and giving for someone else's benefit, blood banking sits within a regulatory category built around donor protection.
Some blood-banking donations rely on apheresis technology, the same separation equipment used in therapeutic plasma exchange, particularly when a donor gives plasma or platelets rather than whole blood. This shared equipment is part of why the two processes get confused, a point covered later in this article.
Blood banks operate under federal blood-establishment regulations, specifically 21 CFR 630.15, and are accredited against the AABB Standards for Blood Banks and Transfusion Services. Source Plasma donors are subject to defined eligibility criteria under this framework, including an annual physician exam, renewed informed consent, and plasma protein levels between 6.0 and 9.0 g/dL, so the collected plasma stays safe for its eventual recipient.
What Is Plasmapheresis?
At a summary level, plasmapheresis is an apheresis technique that separates plasma from the rest of the blood using centrifugation or membrane filtration. When performed therapeutically as Therapeutic Plasma Exchange (TPE), plasmapheresis removes pathogenic substances circulating in a patient's own plasma, such as autoantibodies or immune complexes, and replaces the removed volume with albumin or fresh frozen plasma. This is thought to help manage the patient's own diagnosed condition rather than produce a donation product for someone else.
Because TPE treats a patient rather than qualifying a donor, it is governed clinically by American Society for Apheresis (ASFA) guidelines rather than the donor-eligibility rules described above. An individualized physician determines whether TPE is appropriate and which replacement fluid to use. Readers wanting a fuller explanation may find our guide to what plasmapheresis is helpful, since this article focuses on the blood banking vs plasmapheresis distinction rather than repeating mechanism detail covered there.
Blood Banking vs Plasmapheresis: Key Differences
Blood banking and plasmapheresis-as-TPE rely on the same apheresis technology, but purpose, beneficiary, and oversight differ.
Aspect | Blood Banking | Plasmapheresis (as TPE) | ||
Purpose | Collects and stores blood/plasma for transfusion to others or further manufacture | Removes substances from a patient's own plasma to help manage a diagnosed condition | ||
Who benefits | A third-party recipient or manufacturer | The patient undergoing the procedure | ||
Regulatory framework | FDA blood-establishment regulations (21 CFR 630.15) and AABB accreditation | ASFA clinical practice guidelines and individualized physician oversight | ||
What happens to removed plasma | Collected, tested, and stored or distributed (or compensated as Source Plasma) | Discarded along with the substances it carries | ||
Replacement fluid | Typically none required, or saline | Albumin or fresh frozen plasma | ||
Setting | Blood bank or donation center | Clinical or hospital-based apheresis unit | ||
Frequency | Donation-interval limits set by regulation | Individualized treatment course determined by a physician |
Every blood-banking apheresis donation and every therapeutic plasma exchange session uses the same basic separation technology. What differs is the reason: one supplies blood products to someone else, and the other treats the person on the machine.

Why the Two Get Confused
The confusion largely traces back to shared equipment and shared history. Both processes rely on the same apheresis technology to separate plasma from cellular blood components, so a reader encountering "plasmapheresis" in a donation context and again in a hospital context may reasonably assume it always means the same thing.
There is also a historical reason for the overlap. Plasmapheresis was traditionally performed in blood banks using centrifuge-based techniques, and the term has continued to describe both donation-context plasma collection and therapeutic plasma exchange, even though the two serve different people for different reasons. It is one piece of equipment supporting two different purposes, not a true disagreement about terminology. Readers who want this distinction applied to a closely related term may find our plasma exchange vs plasmapheresis comparison useful as well.
Safety and Oversight
Blood banking donor safety is governed by defined eligibility and monitoring rules meant to protect a healthy person giving blood or plasma voluntarily. In a large retrospective cohort of 11,333 apheresis-based donation procedures, moderate-to-severe donor reactions occurred in about 0.47% of cases, most commonly vasovagal, with female sex, lower pre-donation hematocrit, and greater fluid or red-cell loss identified as risk factors. Donor-safety literature also continues to evaluate donation frequency and longer-term effects on repeat donors, and a scoping review of plasma-donor safety measures confirms that frequency limits and protein thresholds define the blood-banking regulatory context.
Plasmapheresis performed as TPE is overseen differently, taking place under ASFA's evidence-graded clinical framework with individualized physician oversight rather than donor-eligibility rules. Broader safety data suggests adverse events are relatively uncommon; a retrospective analysis of 3,367 apheresis procedures spanning plateletpheresis, TPE, and stem cell collection recorded 90 adverse events (2.7%), mostly citrate reactions and presyncope. Both settings involve trained staff and monitoring, but the considerations differ because a healthy donor and a patient with a diagnosed condition face different risks.
Frequently Asked Questions
Is donating plasma the same as plasmapheresis?
Donating plasma can involve plasmapheresis technology, since some blood banks use apheresis equipment to collect plasma from healthy donors. However, donating plasma is a blood-banking activity meant to help another person, while plasmapheresis performed as a medical treatment removes substances from a patient's own plasma.
What is the difference between blood banking and plasmapheresis?
Blood banking is the collection, testing, storage, and distribution system for blood and plasma donated by healthy people for someone else's benefit. Plasmapheresis, when used therapeutically, is a medical procedure that removes pathogenic substances from a patient's own plasma under a framework focused on the patient rather than donor eligibility.
Does a blood bank perform therapeutic plasma exchange?
Blood banks are generally structured around donor collection and distribution rather than patient treatment, so therapeutic plasma exchange is typically performed in a clinical or hospital-based apheresis unit under physician oversight. The two settings can use similar equipment, but they are organized around different purposes and standards.
Why do blood banks and hospitals use the same type of equipment?
Both settings rely on apheresis technology, which separates plasma from the rest of the blood using centrifugation or membrane filtration. The equipment does not determine the purpose of the procedure, which is why the same machine can support a donation in one setting and a treatment in another.
Is plasmapheresis used for blood donation or medical treatment?
Plasmapheresis can be used in either context, which is part of why the term is often misunderstood. In a donation context it supports blood banking, while in a treatment context it functions as therapeutic plasma exchange for a patient with a diagnosed condition.
How often can someone donate plasma compared to undergoing therapeutic plasma exchange?
Plasma donation frequency is set by federal donor-eligibility regulation, which establishes defined intervals and protein-level requirements to protect the donor. Therapeutic plasma exchange frequency, by contrast, is individualized and determined by a physician based on the patient's condition.
Is plasmapheresis safe?
Plasmapheresis, whether performed in a donation or treatment context, is generally considered to carry a relatively low rate of serious adverse events when performed by trained staff under appropriate oversight. Safety data and monitoring still differ between the two contexts, since a healthy donor and a patient with a diagnosed condition face different risk considerations.
Key Takeaways
- Blood banking is the donation and storage system that collects blood and plasma from healthy donors for a third party's benefit, while plasmapheresis performed as therapeutic plasma exchange is a medical procedure for the patient undergoing it.
- Blood banking vs plasmapheresis ultimately comes down to purpose and regulation, not the equipment involved, since both rely on the same apheresis technology.
- Safety is actively monitored in both settings, but through different frameworks suited to a healthy donor versus a patient with a diagnosed condition.
- The historical overlap in terminology, not a true overlap in purpose, is the main reason blood banking and plasmapheresis are often confused.
Considering Therapeutic Plasma Exchange?
If you are exploring plasmapheresis as a treatment rather than a donation process, learn more about Humanaut Health's Therapeutic Plasma Exchange program.
References
- Cervantes, C.E., Bloch, E.M., Sperati, C.J. "Therapeutic Plasma Exchange: Core Curriculum 2023." American Journal of Kidney Diseases, 2023; 81(4):475-492. DOI: 10.1053/j.ajkd.2022.10.017
- U.S. Food and Drug Administration. "Donor Eligibility Requirements Specific to Whole Blood, Red Blood Cells, and Plasma Collected by Apheresis." 21 CFR § 630.15, Code of Federal Regulations, Title 21, Part 630, Subpart B. Available at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-F/part-630/subpart-B/section-630.15
- AABB. Standards for Blood Banks and Transfusion Services, 35th ed. 2026. Available at: https://www.aabb.org/standards-accreditation/standards/blood-banks-and-transfusion-services
- Hoad, V.C., Castren, J., Norda, R., Pink, J. "A donor safety evidence literature review of the short- and long-term effects of plasmapheresis." Vox Sanguinis, 2024; 119:94-101. DOI: 10.1111/vox.13512
- Schroyens, N., D'aes, T., De Buck, E., Mikkelsen, S., Tiberghien, P., van den Hurk, K., Erikstrup, C., Compernolle, V., Van Remoortel, H. "Safety and protection of plasma donors: A scoping review and evidence gap map." Vox Sanguinis, 2024; 119(2):110-120. DOI: 10.1111/vox.13544
- Yuan, S., Gornbein, J., Smeltzer, B., Ziman, A.F., Lu, Q., Goldfinger, D. "Risk factors for acute, moderate to severe donor reactions associated with multicomponent apheresis collections." Transfusion, 2008; 48(6):1213-1219. DOI: 10.1111/j.1537-2995.2008.01674.x
- Philip, J., Sarkar, R.S., Pathak, A. "Adverse Events Associated with Apheresis Procedures: Incidence and Relative Frequency." Asian Journal of Transfusion Science, 2013; 7(1):37-41. DOI: 10.4103/0973-6247.106730